Provided by Tiger Fintech (Singapore) Pte. Ltd.

SIHUAN PHARM

1.670
0.000
Volume:58.15M
Turnover:96.76M
Market Cap:15.33B
PE:-65.31
High:1.700
Open:1.680
Low:1.640
Close:1.670
52wk High:1.710
52wk Low:0.491
Shares:9.18B
HK Float Shares:9.18B
Volume Ratio:0.42
T/O Rate:0.63%
Dividend:0.01
Dividend Rate:0.65%
EPS(LYR):-0.026
ROE:-6.73%
ROA:-0.93%
PB:3.20
PE(LYR):-65.31
PS:6.68

Loading ...

Sihuan Pharmaceutical Receives Chinese Regulatory Nod for Human Studies of Diabetes Drug

MT Newswires Live
·
Yesterday

BRIEF-Sihuan Pharmaceutical Says P052 Injection Approved For Ind

Reuters
·
Yesterday

SIHUAN PHARM (00460): Subsidiary Huisheng Bio Receives IND Approval for Self-Developed GLP-1R/GCGR Dual-Target Innovative Drug P052 Injection

Stock News
·
Yesterday

Sihuan Pharmaceutical - P052 Injection Independently Developed by Huisheng Biopharmaceutical Approved for Ind

THOMSON REUTERS
·
Yesterday

SIHUAN PHARM (00460): Medical Aesthetics Surge and Innovation Drug Monetization Drive Valuation Recovery

Stock News
·
Sep 05

Sihuan Pharmaceutical Announces Spin-Off and Separate Listing of Xuanzhu Biopharm on Hong Kong Stock Exchange

Reuters
·
Sep 04

HK Movers|Pharma Stocks Jumped. JW THERAP Surged 12%; HBM HOLDINGS Up 10%; SIHUAN PHARM Rose 8%;

Tiger Newspress
·
Sep 03

Stock Track | Sihuan Pharma Soars 9.33% on Share Buyback and Growth Prospects

Stock Track
·
Sep 03

BUZZ-Sihuan Pharma hits 3-1/2-year peak on share buyback, growth optimism

Reuters
·
Sep 03

SIHUAN PHARM (00460) Repurchases 13.096 Million Shares for HK$19.572 Million on September 2

Stock News
·
Sep 02

Sihuan Pharmaceutical Files Next Day Disclosure with HKEX, Announces Repurchase of 13,096,000 Shares at HKD 19.57 Million

Reuters
·
Sep 02

Xuanzhu Biology Plans Hong Kong IPO, Receives CSRC Filing Notice

Deep News
·
Sep 01

SIHUAN PHARM (00460) Plans to Establish AI R&D Company with Shenyuanzhi Pharmaceutical to Jointly Explore AI-Driven Medical Aesthetics Product Development

Stock News
·
Sep 01

Sihuan Pharmaceutical Partners with dProtein to Launch AI-Driven Medical Aesthetic R&D Company

Reuters
·
Sep 01

Sihuan Pharmaceutical - Jointly Established AI R+D Co With Units to Explore Development of AI-Driven Novel Medical Aesthetic Products

THOMSON REUTERS
·
Sep 01

SIHUAN PHARM (00460): Chen Yanling to be Appointed as Member of Nomination Committee

Stock News
·
Aug 29

Sihuan Pharmaceutical Announces Ms. Chen Yanling's Appointment to Nomination Committee

Reuters
·
Aug 29

BRIEF-Sihuan Pharmaceutical Posts H1 Gross Profit RMB757.3 Million

Reuters
·
Aug 29

Sihuan Pharmaceutical Returns to Profitability in H1; Shares Up 4%

MT Newswires Live
·
Aug 29

SIHUAN PHARM (00460) Reports Interim Results with Shareholder Profit of RMB103 Million, Turning from Loss to Profit Year-on-Year

Stock News
·
Aug 29